MoonLake Immunotherapeutics Announces Board Changes and Incentives

TipRanksDec 19 05:57

Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18 03:00

Stifel Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Raises Target Price to $77

Futu NewsDec 17 10:31 · Ratings

We Think MoonLake Immunotherapeutics (NASDAQ:MLTX) Can Afford To Drive Business Growth

Simply Wall StDec 16 19:08

Jefferies Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $65

Futu NewsDec 11 21:31 · Ratings

LifeSci Capital Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $75

Futu NewsDec 10 22:32 · Ratings